Tong Wei

Dr. Tong Wei

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2026 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
JXJuan Xu
Juan Xu
TWTong Wei
Tong Wei
LLLin Liang
Lin Liang
XLXiaofeng Lu
Xiaofeng Lu
JLJun Li
Jun Li
SCSongwen Chen
Songwen Chen

26 March 2025 in EP Europace
Verified
Journal Article
Open access
XLXiaofeng Lu
Xiaofeng Lu
XLXintao Li
Xintao Li
YLYong Lu
Yong Lu
JXJuan Xu
Juan Xu
SPshi peng
shi peng
SCSongwen Chen
Songwen Chen

12 August 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
ZZzikan zhong
zikan zhong
CJChenyang Jin
Chenyang Jin
XLXudong Li
Xudong Li
LGLongzhe Gao
Longzhe Gao
YYYutong Ye
Yutong Ye
JXJuan Xu
Juan Xu
Background/Objectives: Ischemia-reperfusion injury (IRI) contributes significantly to cardiomyocyte death following myocardial infarction, largely through sustained inflammatory signaling. This study aimed to identify stress-responsive deubiquitinating enzymes involved in cardiomyocyte injury under ischemic stress. Methods: HL-1 cardiomyocytes were subjected to oxygen-glucose deprivation and reoxygenation (OGD/R), followed by transcriptomic analysis, genetic manipulation of Usp31, biochemical assessment of p65 ubiquitination, NF-κB reporter assays, and in vitro deubiquitinase activity assays using sodium tanshinone IIA sulfonate (STS). Results: Usp31 was persistently upregulated in HL-1 cardiomyocytes after OGD/R. Depletion of Usp31 improved cell viability and reduced lactate dehydrogenase (LDH) release under OGD/R conditions. Mechanistically, Usp31 stabilized p65 and supported NF-κB activation, whereas Usp31 deficiency increased p65 ubiquitination and limited NF-κB transcriptional activity. STS inhibited recombinant Usp31 enzymatic activity under the experimental conditions tested and reduced Usp31-associated NF-κB activation and cardiomyocyte injury in cellular assays. Conclusions: These findings identify Usp31 as a candidate regulator of NF-κB-associated inflammatory responses in cardiomyocytes and support STS as a pharmacological modulator of Usp31-associated signaling with potential relevance to myocardial ischemic injury.